Our story begins with a meeting back in 2011 between the founders, Oren Goldshtein and Dr. Eyal Orion, MD. The two of them identified the existing heart failure management as a clear unmet clinical need and tried to imagine the next stage of implantable hemodynamic monitoring, without limiting themselves with technological and medical constraints. At that time, the only way to really understand what was happening in the patient’s heart was to insert a catheter with a pressure sensing tip inside a hospital environment, which proved costly and impractical.
What if there is a way to harness technology so that we can have the most accurate and specific physiological indication available daily and remotely at home?
Utilizing and weaving together their professional backgrounds, they conceived of the V-LAP to remotely monitor the heart’s left atrial pressure. With this foresight, our team understands the power of bringing digitally generated data from the heart and using AI-based analysis to improve treatment decisions and outcomes for patients suffering from heart failure.
Fast forward to the present day, and Vectorious’ team has successfully implanted in-heart micro computers in multiple countries across Europe and Israel. Our clinical study has been demonstrated huge potential in helping millions of people living with heart failure to take control and manage their disease, keeping them stable, out of hospitals, and living longer, fuller lives.
Every patient with chronic heart disease, will be remotely monitored by in-body micro-sensors.
This would enable a personalized, data driven treatment, at the convenience of the patient's home and would halt the disease’s deterioration.
We are on a mission of harvesting pressure data from the heart remotely with the world's first in-heart microcomputer.
Based on this data we will be providing valuable insights that will help caregivers make informed decisions to halt heart failure progression.
Eyal is a serial Med-Tech entrepreneur. Besides leading Vectorious Medical Technologies, Eyal is co-founder and active board member in four revenue stage medical device companies in the field of cardiovascular surgery, hemodialysis, heart failure, neurovascular and pulmonology: Vascular Graft Solutions, Laminate Medical Technologies, Perflow Medical and BodyVision Medical Technologies.
Eyal was selected by Goldman Sacks as one of the most intriguing 100 entrepreneurs in the world as part of the Builders and Innovators Summit, 2018.
Eyal Holds an MD from the Technion-Israel Institute of Technology and an MBA from Tel-Aviv University.
VP QA & RA
Vadim joined the team after 27 years of experience leading Quality and Regulatory Affairs for Medical Device Global market leaders - Toshiba Medical, Johnson & Johnson, and Philips Healthcare.
Vadim holds a B.Sc. in mechanical engineering, MSc in Quality and Reliability Engineering and MBA from theTechnion Israel.
Dedi has accumulated extensive experience in the professional leadership of clinical studies, both in terms of design and execution. Before joining Vectorious, Dedi served as Clinical Trials Manager and Clinical Specialist at Paieon Medical and Senior Product Manager at Volcano Corporation with a focus on structural heart disease procedures such as TAVI and CRT. For V-Wave, a biomedical startup, in the field of heart failure, Dedi worked in close contact with heart failure specialists, overcoming all regulatory issues linked to the clinical aspects of the product deployment.
Dedi holds a BSc in Biotechnology engineering from the Ben Gurion University of the Negev and an MBA from the Recanati Business school, Tel Aviv University.
Before joining Vectorious in 2017, Matan served for seven years in the technological unit of the IDF Intelligence Corps, a position in which he developed expertise in a variety of disciplines within electronic engineering, including magnetic fields, RF and energy circuits. Matan was released as a major after completing a term as a group manager of automation engineers leading multiple critical projects within tight time constraints.
Matan holds a BSc in physics and a BSc in electrical engineering from the Technion, Israel institute of Technology.
Director of Mechanics and Engineering
With over 10 years in the mechanical engineering field in the medical device industry, Tomer has vast experience in R&D and NPI of Class I, II and III medical devices.
Prior to joining Vectorious, Tomer worked as Mechanical Engineer at Bausch & Lomb Surgical.
Tomer holds a BSc in Mechanical Engineering from the UMSL & Washington University Joint Program and an MSc in Mechanical Engineering from the Technion.
Director of operations
Amihay has more than 15 years of experience in the medical device industry, 9 of which were with Medinol, where he served as a process group manager. Previously, Amihay held various R&D and engineering roles at Medinol and in other innovative medical device companies, such as Ovalum vascular and Optonol (acquired by Alcon laboratories). Amihay holds a B.Sc. in Advanced Material Engineering from the Jerusalem college of engineering.
Director of Product
Gil joined the Vectorious team with the goal of turning Vectorious to the name brand of IHM and allow large scale IHM based treatment.
Prior to joining Vectorious in 2021, Gil was a senior product manager in SolarEdge, responsible for breakthrough core solutions of the company accounting for a major part of the company's revenue. In his position in SolarEdge, he was responsible for end-to-end product management of the solutions, from conception to delivery in multi-disciplinary products that include hardware, firmware, software, monitoring solutions and customer mobile applications.
Gil holds a MSc in Electrical Engineering from the Technion, Israel Institute of Technology
Head of HR
Dana is an organizational psychologist, personal coach, and group facilitator. Prior to Vectorious, Dana served as an organizational consultant at Deloitte's Human Capital Consulting.
Dana holds a master degree in organizational psychology and a bachelor degree in behavioral science, both from Ben Gurion University of the Negev.
Director of Regulatory Affairs
Before joining Vectorious in 2015, Elina graduated Cum Laude both in her BSc and MSc in biomedical engineering at Tel Aviv University.
Following her master’s degree in the Cardiovascular System Laboratory, Elina started working at Vectorious, taking a major role as R&D project manager, leading various R&D activities, and later as Regulatory Affairs Director.
Senior QA Manager
Daniel joined Vectorious after working in several Quality Assurance and Regulatory Affairs roles for more than 12 years in medical device companies, dealing with class II and III medical devices, and a variety of products, including Active Implants, Biomaterials, Hardware and Software.
Prior to joining Vectorious, Daniel served as QA Manager in EarlySense Ltd.
Daniel is a Certified Quality Engineer (CQE) and holds a B.Sc. and M.Sc. in Biomedical Engineering from Tel Aviv University.
Integration and Testing Team Leader
Michael has extensive experience in testing and system integration. He has developed HW and SW infrastructures in order to automate Set-Ups and shorten testing times. Before joining Vectorious Michael was part of the System Tests team at Texas Instruments (TI) for 3 years, performing system SW tests. Prior to TI Michael served as SW / HW testing engineer in the technological unit of the IDF Intelligence Corps.
Michael holds ISTQB certification.
Senior R&D Manager
Or joined Vectorious in 2016, and brings vast experience in the development of manufacturing processes, testing capabilities, and various R&D activities.
Or received his BSc in biomedical engineering from Tel Aviv University.
Clinical Trial Manager
Reuth has vast experience in the field of clinical trials: from electronic case report forms architecture, via clinical data management through clinical trials management. She holds an MSc degree in Neurobiology, from the Faculty of Medicine of The Hebrew University of Jerusalem. Currently, manages the company’s clinical studies in both Europe and Israel.
Algorithmics and ASIC Team Leader
Maoz has extensive experience in a wide range of fields, including algorithms, radio and energy circuits, communications and optics. Prior to joining Vectorious, he was a systems architect for Innoviz Technologies, which develops autonomous vehicle sensors, and for Ceragon Networks, which specializes in RF and Ethernet communications.
He served in the technological unit of the IDF Intelligence Corps as an electronics and system engineer for six years.
Maoz holds a BSc in physics and a BSc in electrical engineering from Tel-Aviv University, Israel.
Software Team Leader
Harel joined Vectorious after six years of service in an elite technology unit of the IDF’s Intelligence Corps, where he developed expertise in various software disciplines in multiple projects.
Harel holds a BSc in computer engineering from Bar Ilan University.
Hardware Team Leader
Yaniv is a senior RF System Engineer with more than 20 years of experience in the RF industry with specialization in mmWave technologies, defining requirements for new products, and owning customer-facing integrations and platform designs.
He is the co-inventor and holder of multiple US patents for mmW applications.
Yaniv holds a BSc in electrical engineering from the Tel Aviv University, Hosted by Holon Institute of Technology (HIT).
Support Team Leader
Mika leads the support in patients and physicians involved in the V-LAP study, takes ownership of technical issues and investigates problems through to resolution.
Mika holds a BSc in biomedical engineering from Tel Aviv University.
Mechanical Engineering Team Leader
Ido joined Vectorious after six years of service in the technological unit of the IDF’s Intelligence Corps, where he gained a vast experience in mechanical design of complex systems and in multiple mechanical disciplines.
Ido holds a BSc Summa Cum Laude and an MSc with thesis in the field of MEMS, both in Mechanical Engineering from the Technion as part of the “Brakim” excellence program.
Jessica Specialized in the healthcare industry with over 7 years in the medical device segment, Jessica worked in start-ups (Nano Retina, M.S.T), large companies (Essilor, Teva Pharmaceuticals), and a renowned hospital (Institut Curie). Jessica grew up in France, holds a MSc in Engineering with a major in Health & Technology, and also studied at Concordia University in Canada and Beijing University of Technology in China.
Professor Di Mario is Professor of Cardiovascular Medicine and Director of Structural Interventional Cardiology at Careggi University Hospital in Florence, Italy, and Honorary Consultant in Interventional Cardiology at Royal Brompton Hospital, in London, England.
Prior to this, he was the President of the European Association of Cardiovascular Interventions of the European Society of Cardiology and President-Elect of the EuroCTO Club. Internationally regarded as an expert in his field, Professor Di Mario Prior also serves on the editorial board of leading academic journals.
Professor Abraham (MD, FACP, FACC. FAHA, FESC, FRCPE) is the College of Medicine Distinguished Professor and Professor of Medicine, Physiology, and Cell Biology at The Ohio State University. Internationally-known as a heart failure expert and researcher, Professor Abraham has been a primary investigator in landmark studies in the field, including the pivotal study of the CardioMEMS system.
Prior to his work at Charité, Professor Anker served as an Innovative Clinical Trials (W3) at University Medical Center Göttingen. He is Councilor of the Board European Society of Cardiology (ESC, 2014-16).
Since 2006, he has been a board member of the Heart Failure Association (HFA) of the ESC, additionally, serving as its President from 2012-14 and is now chairing its Committee on Regulatory Affairs. He is also the founding editor-in-chief of ESC Heart Failure, the first open access heart failure journal, and serves on the editorial boards of five scientific journals, including European Heart Journal, European Journal of Heart Failure and IJC.
Dr. Sievert is the Director of the CardioVascular Center Frankfurt and a Professor at the University of Frankfurt. In addition, he serves as an honorary professor and a visiting professor at leading universities in the UK, USA, and China, too.
Dr. Sievert has been the principal investigator of many clinical trials in the field of interventional cardiology and has authored more than 300 manuscripts and 700 abstracts in peer-reviewed journals, 125 books and book contributions. He is a member of the editorial council at several prestigious medical journals.
Vectorious is always on the lookout for top talent. If you have passion and a big heart, check out our open positions and apply.
Subscribe to get Vectorious' Newsletter with the latest news and clinical updates from the VECTOR-HF study